A Pilot Randomized Controlled Trial of the Hopeful and Healthy Living Program
(HHL)
Enhancing Social Connection, Health, and Aging in Older Persons: A Pilot Randomized Trial of the Hopeful and Healthy Living (HHL) Program
2 other identifiers
interventional
60
1 country
2
Brief Summary
The goal of this clinical trial is to learn if a novel psychosocial intervention is effective in helping adults over 50 with serious mental illness (SMI) increase their social connections and participate in more healthy lifestyle activities. The Hopeful and Healthy Living (HHL) intervention combines social skills training and training in cognitive self-management strategies in order to help older adults build healthy lifestyle and social routines. We predict that:
- Individuals who participate in the HHL intervention will improve more in perceived social support (i.e., what people get from relationships such as reliance, reassurance of worth, attachment) and loneliness at the 4-, 8-, and 12-month follow-up assessments than those who receive treatment as usual (TAU).
- Individuals who participate in the HHL intervention will improve more in overall psychosocial functioning at the 4-, 8-, and 12-month follow-up assessments than those who receive TAU.
- Individuals who participate in the HHL intervention will improve more in cognitive functioning at the 4-, 8-, and 12-month follow-up assessments than those who receive TAU.
- Individuals who participate in the HHL intervention will improve more in healthy behaviors (sleep, activity, diet) at the 4-, 8-, and 12-month follow-up assessments than those who receive TAU. In this trial, participants will be either receive the HHL intervention or participate in their regular treatment activities (treatment as usual). HHL vs. TAU will be compared to see if there are any differences in social support, cognition, loneliness, psychosocial functioning, or healthy lifestyle activities including physical activity, sleep, and diet. Participants will be asked to complete an interview-based assessment at baseline, 4-months, 8-months, and 12-months. After completing the baseline assessment, those who are in the experimental group will participate in the 16-week long HHL group intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2025
CompletedFirst Submitted
Initial submission to the registry
April 16, 2025
CompletedFirst Posted
Study publicly available on registry
April 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2028
April 25, 2025
April 1, 2025
3.4 years
April 16, 2025
April 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Montreal Cognitive Assessment (MOCA)
Standardized screening tool used for assessing cognition.
Baseline, 4-, 8-, 12- month followup
The Cognitive Self-Efficacy Scale
10-item measure that assesses confidence in everyday cognitive tasks.
Baseline, 4-, 8-, 12- month followup
The DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure
Adult will be used to assess and statistically control for mental health symptom severity.
Baseline, 4-, 8-, 12- month followup
The UCLA Loneliness Scale-3-item instrument
3-item screening tool for loneliness.
Baseline, 4-, 8-, 12- month followup
The Social Provisions Scale
24-item instrument that will be used to measure various types of social supports.
Baseline, 4-, 8-, 12- month followup
The Physical Activity Scale for the Elderly (PASE)
Standardized measurement of physical activity related to exercise, work, recreation, and daily living activities.
Baseline, 4-, 8-, 12- month followup
Starting the Conversation
A brief standardized survey for assessing daily eating habits.
Baseline, 4-, 8-, 12- month followup
Pittsburg Sleep Quality Index (PSQI)
An 11-item tool that is used to assess sleep quality and routines.
Baseline, 4-, 8-, 12- month followup
Secondary Outcomes (1)
HHL Group Satisfaction and Feedback Survey
4-month assessment only
Study Arms (2)
HHL group participants
EXPERIMENTALParticipants will complete the 16-week manualized HHL intervention. This group intervention will occur weekly for 90 minutes. These participants will also continue with treatment as usual.
Treatment as usual
NO INTERVENTIONParticipants assigned to this arm will continue with treatment as usual.
Interventions
The HHL intervention is a 16-week long, manualized group intervention. Classes will be held weekly for 90 minutes. The class covers 15 topics centered on building social connections, developing healthy lifestyle routines around eating, exercise, and sleep. Each class will target one social skill (i.e. starting conversations) and one cognitive self-management strategy (i.e. memory tips), which will be taught and practiced in class. Each class also includes a facilitated exercise component and individually tailored take home application activity.
Eligibility Criteria
You may qualify if:
- years or older, diagnosis of a serious mental illness, and a member of Center Club or Transitions of Boston
You may not qualify if:
- Diagnosis of dementia or other progressive neurological disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston University Charles River Campuslead
- Bay Cove Human Servicescollaborator
Study Sites (2)
Bay Cove Center Club
Boston, Massachusetts, 02114, United States
Bay Cove Transitions of Boston
Boston, Massachusetts, 02122, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Susan McGurk, PhD
Boston University
- PRINCIPAL INVESTIGATOR
Kim Mueser, PhD
Boston University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2025
First Posted
April 23, 2025
Study Start
March 12, 2025
Primary Completion (Estimated)
July 31, 2028
Study Completion (Estimated)
July 31, 2028
Last Updated
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share